...
首页> 外文期刊>Clinical transplantation. >Association studies of toll-like receptor gene polymorphisms with allograft survival in renal transplant recipients of north india
【24h】

Association studies of toll-like receptor gene polymorphisms with allograft survival in renal transplant recipients of north india

机译:印度北部肾移植受者中Toll样受体基因多态性与同种异体移植存活的相关性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Organ transplantation itself inevitably activates the innate immune system by Toll-like receptors (TLRs), potentially leading to allograft rejection and graft failure. We evaluated the possible association of TLR2, TLR3, and TLR9 polymorphisms of donor-recipient pairs and acute rejection in renal transplant patients of North India. TLR2 (-196 to -174 del), TLR3 (c.1377C/T; rs 3775290), and TLR9 (+2848G/A; rs 352140) were genotyped using DNA samples from 200 donor-recipient pairs of live donor kidney transplantation by applying Restriction Fragment Length Polymorphism (RFLP) methodology. The variant allele frequency of TLR2 (-196 to -174 del) was significantly different between recipients and donors (7.5% vs. 5.0%; p=0.049; OR=3.9; 95%CI=1.01-15.32). However, no significant association for allograft rejection was observed in transplant recipients for TLR3 and TLR9. Interestingly, a low prevalence of AA genotype of TLR9+2848G>A was observed in rejecters when compared with non-rejecters, demonstrating protective association with allograft rejection (OR=0.30, 95% CI=0.12-0.88, p=0.028). An allele in patients was also observed to be associated with higher rejection-free survival (log-rank=0.044). These TLR gene polymorphisms, upon further evaluation, may be helpful in elucidation of immunobiological mechanisms associated with renal graft rejection.
机译:器官移植本身不可避免地通过Toll样受体(TLR)激活先天免疫系统,可能导致同种异体移植排斥和移植失败。我们评估了印度北部肾移植患者中供体-受体对的TLR2,TLR3和TLR9多态性与急性排斥反应的可能关联。使用来自200个活体供体肾脏移植的供体-受体对的DNA样品对TLR2(-196至-174 del),TLR3(c.1377C / T; rs 3775290)和TLR9(+ 2848G / A; rs 352140)进行基因分型。应用限制性片段长度多态性(RFLP)方法。 TLR2的变异等位基因频率(-196至-174 del)在受体和供体之间显着不同(7.5%vs. 5.0%; p = 0.049; OR = 3.9; 95%CI = 1.01-15.32)。但是,在TLR3和TLR9的移植接受者中未观察到同种异体移植排斥的显着关联。有趣的是,与非排斥者相比,在排斥者中观察到TLR9 + 2848G> A的AA基因型的患病率低,证明了同种异体移植排斥的保护性关联(OR = 0.30,95%CI = 0.12-0.88,p = 0.028)。还观察到患者中的等位基因与较高的无排斥存活相关(log-rank = 0.044)。这些TLR基因多态性,经过进一步评估,可能有助于阐明与肾移植排斥反应相关的免疫生物学机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号